M40 (M 40)
has the same N-terminal amino acid sequence as galanin 1-13; binds to neuronal galanin receptor, thereby making it a galanin antagonist
Also Known As:
M 40; Pro-Pro-2-(Ala-Leu)-Ala-galanin (1-13)-amide; galanin (1-13)-amide, Pro-Pro-(Ala-Leu)(2)-Ala-; galanin (1-13)-amide, prolyl-prolyl-(alanyl-leucyl)(2)-alanyl-; galanin(1-13)-Pro-Pro-(Ala-Leu)(2)-Ala amide
Networked: 72
relevant articles (4 outcomes,
6 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Harty, Ronald N:
3 articles
(01/2022 - 11/2012)
|
2. | Freedman, Bruce D:
2 articles
(01/2022 - 01/2016)
|
3. | Ruthel, Gordon:
2 articles
(01/2022 - 01/2016)
|
4. | Erevik, Eilin Kristine:
1 article
(06/2022)
|
5. | Leino, Tony:
1 article
(06/2022)
|
6. | Mentzoni, Rune Aune:
1 article
(06/2022)
|
7. | Pallesen, Ståle:
1 article
(06/2022)
|
8. | Smith, Otto R F:
1 article
(06/2022)
|
9. | Syvertsen, André:
1 article
(06/2022)
|
10. | Barrett, Emma:
1 article
(01/2022)
|
Related Diseases
1. | Myocardial Infarction
06/01/1992
- " Supranormal Ig levels (A > or = 300, G > or = 1,200) or subnormal Ig levels (M < 40 mg/100 ml) were seen in patients with one or several risk factors (diabetes mellitus, alcohol abuse) or a history of previous myocardial infarction. " 02/01/2003
- " At the baseline, Group L had a significantly lower LVEF (H 55+/-7 vs. M 40+/-3 vs. L 30+/-3%, P<0.05), significantly greater LVDd (49+/-6 vs. 52+/-7 vs. 56+/-6 mm, P<0.05), and a higher incidence of anterior infarction (P<0.01) compared with Groups H and M, whereas there were no difference in age, sex, coronary risk factors, the incidence of multivessel disease, prior myocardial infarction, peak WR or peak VO(2) among the three groups. "
|
2. | Pancreatitis
|
3. | Infarction (Infarctions)
02/01/2003
- " At the baseline, Group L had a significantly lower LVEF (H 55+/-7 vs. M 40+/-3 vs. L 30+/-3%, P<0.05), significantly greater LVDd (49+/-6 vs. 52+/-7 vs. 56+/-6 mm, P<0.05), and a higher incidence of anterior infarction (P<0.01) compared with Groups H and M, whereas there were no difference in age, sex, coronary risk factors, the incidence of multivessel disease, prior myocardial infarction, peak WR or peak VO(2) among the three groups. "
|
4. | Fibrosis (Cirrhosis)
|
5. | Acidosis
|
|
Related Drugs and Biologics
Related Therapies and Procedures